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Abstract The aim of this study was to examine the effects
of cadmium in concentrations relevant to those detected
in human serum on cyclooxygenase-1 (COX-1) and
cyclooxygenase-2 (COX-2) expression at mRNA, protein,
and enzyme activity levels in THP-1 macrophages. Macro-
phages were incubated with various cadmium chloride
(CdCl2) solutions for 48 h at final concentrations of 5 nM,
20 nM, 200 nM, and 2 μM CdCl2. The mRNA expression
and protein levels of COXs were analyzed with RT-PCR and
Western blotting, respectively. Prostaglandin E2 (PGE2) and
stable metabolite of thromboxane B2 (TXB2) concentrations
in culture media were determined using ELISA method. Our
study demonstrates that cadmium at the highest tested concen-
trations modulates COX-1 and COX-2 at mRNA level in
THP-1 macrophages; however, the lower tested cadmium
concentrations appear to inhibit COX-1 protein expression.
PGE2 and TXB2 production is not altered by all tested Cd
concentrations; however, the significant stimulation of PGE2
and TXB2 production is observed when macrophages are ex-
posed to both cadmium and COX-2 selective inhibitor, NS-
398. The stimulatory effect of cadmium on COXs at mRNA
level is not reflected at protein and enzymatic activity levels,
suggesting the existence of some posttranscriptional, transla-
tional, and posttranslational events that result in silencing of
those genes’ expression.
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Introduction
Cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2)
are the bifunctional enzymes catalyzing the conversion of ar-
achidonic acid (AA) to prostaglandin H2 (PGH2) in two se-
quential reactions, the first being the generation of prostaglan-
din G2 (PGG2) (cyclooxygenase reaction) followed by the
reduction of PGG2 to PGH2 (peroxidase reaction). The gener-
ated PGH2 is the precursor of biologically active prostanoids
such as prostaglandin D2 (PGD2), prostaglandin E2 (PGE2),
prostaglandin I2 (PGI2), prostaglandin F2α (PGF2α) and
thromboxane A2 (TXA2) [1, 2]. COX-1 and COX-2 enzymes
share 60 % identity in their amino acid sequences [3]. They
exist as homodimers; each subunit consists of three domains,
the epidermal growth factor domain, the membrane binding
domain, and the catalytic domain containing the cyclooxygen-
ase and peroxidase active sites [3].
COX-1, constitutively expressed in almost all cell types,
but also inducible in some systems [4], was previously con-
sidered to be involved in physiological processes and playing
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no role in inflammation [4]. However, according to newer
concept, COX-1 is also involved in inflammatory process [2,
5]; for example, COX-1 not only is responsible for the initial
prostanoid response to inflammatory stimuli [6] but also con-
tributes to the resolution of inflammation [4]. The human
COX-1 gene (Ptgs1) expression is developmentally controlled
and can be upregulated by tumor-promoting phorbol esters or
growth factors [7]. The regulatory elements of this gene in-
clude SP1 binding site and activator protein-1 (AP-1) site [4,
7]; however, the transcriptional control of COX-1 gene ex-
pression was not well studied [7]. The products of COX-1
enzyme are thromboxane A2 (being metabolized to its stable
metabolite, TXB2) and (PGE2 [6].
COX-2 is an enzyme highly inducible by pro-inflammatory
cytokines, tumor promoters, mitogens, and growth factors in a
variety of cell types, including monocytes [8], which results in
increased prostaglandin release [5]. According to newer con-
cept, COX-2 is the major contributor to prostanoid synthesis
as inflammation progresses [6]. COX-2 gene (Ptgs2) contains
several potential transcriptional regulatory elements in the 5′-
flanking region: peroxisome proliferator response element
(PPRE), two nuclear factor kappa B (NF-κB) sites, one spec-
ificity protein 1 (Sp1) site, two cyclic AMP response elements
(CRE), one nuclear factor for interleukin-6 expression (NF-
IL6) motif, two AP-1 sites, E-box, and TATA box [4, 7, 9].
Transcriptional regulation of COX-2 gene is very complex; it
can involve numerous signaling pathways, and the
mechanism varies depending on the specific stimulus and
the cell type [7]. The main product of COX-2 enzyme is
PGE2 [6].
Cadmium is a toxic and carcinogenic heavy metal that
poses nowadays a serious threat to human health because it
is ubiquitously distributed in the environment and the food,
tobacco smoke, and ambient air constitute the most significant
sources of cadmium exposure for the general population [10,
11]. Cadmium was found to be immunomodulator; it may
modify cell-mediated and humoral immune response, which
may be associated with the occurrence of allergic, inflamma-
tory diseases, and cancers [12, 13]. The target cells for heavy
metals action such as cadmium are lymphocytes and macro-
phages, which participate in humoral immune response. As a
result of toxic action of cadmium, the pro-inflammatory, pro-
coagulatory, and chemotactic factors are released, activating
macrophages to produce cytokines and to development of the
further stages of immune reaction [12]. Cadmium was found
to cause upregulation of some mediators and markers of in-
flammation [11]. A number of studies investigated the effect
of cadmium on COX-2 mRNA [8, 14–19], protein expression
[14, 16, 18, 20–25], and enzymatic activity [16–18, 24, 26,
27]. Most of them demonstrated a stimulatory effect of this
metal on COX-2 in different experimental models [8, 16–19,
21–27]. However, a few reports suggested cadmium to exert
either inhibitory action [14, 15] or no effect [20] on COX-2.
The impact of cadmium onCOX-1was rather poorly analyzed
in literature: only a few studies dealt with this issue, suggest-
ing either no [16, 28] or stimulatory effect [17].
THP-1 cells model has some advantages over human mac-
rophages isolated from blood of cadmium-exposed people.
Their homogenous genetic background minimizes the degree
of variability in the cell phenotype [29]. Such cell model elim-
inates the influence of other environmental factors that may
interfere with the examined mechanisms of cadmium action.
Therefore, THP-1 cells experimental system represents a con-
venient model for the studies of molecular mechanisms of
cadmium action on macrophages in relation to inflammatory
processes [29].
The aim of this study was to examine the effects of cadmi-
um in low concentrations (relevant to levels detected in human
serum) on activity and expression of COX-1 and COX-2.
Materials and Methods
Materials
The materials used include anti-mouse IgG FITC conjugated
(Sigma-Aldrich, Poland), antibiotics (penicillin and strepto-
mycin) (Sigma-Aldrich, Poland), Bakerbond columns (Witko
Group, Poland), cadmium chloride (Sigma-Aldrich, Poland),
cDNA Reverse Transcription Kit (Life Technologies, USA),
COX-1 and COX-2 mouse monoclonal antibody (Santa Cruz,
Germany), FBS (ALAB, Poland), goat anti-mouse IgG-HRP
(Santa Cruz, Germany), Micro BCA Protein Assay kit (Ther-
mo Scientific, USA), monoclonal anti-β-actin anti-
body(1:200; clone AC-74, Sigma Aldrich, Poland), nitrocel-
lulose membrane (Thermo Scientific, Pierce Biotechnology,
USA), NS-398 (Sigma-Aldrich, Poland), PBS (Biomed-Lu-
blin, Poland), phorbol 12-myristate13-acetate (PMA) (Sig-
ma-Aldrich, Poland), Precision Plus Protein Kaleidoscope
Standards (Bio-Rad, Poland), Prostaglandin E2 EIA Kit (Cay-
man, USA), RNAqueous Mini Kit (Life Technologies, USA),
RPMI medium (Biomed-Lublin, Poland), Super Signal West
Pico Chemiluminescent Substrate (ALAB, Poland), Taqman
Gene Expression Assays (Applied Biosystems, USA), THP-1
cells (American Type Culture Collection ATCC, Rockville,
USA), and Thromboxane B2 EIA Kit (Cayman, USA).
Cell Culture and Treatment
The experiments were conducted on macrophages derived
from a human monocytic cell line THP-1. The differentiation
of THP-1 cells into macrophages was achieved by administra-
tion of 100 nM PMA and further incubation for 24 h. The
adherent macrophages were washed three times with PBS
and then incubated with cadmium chloride (CdCl2) solutions
for 48 h at 37 °C in 5 % CO2. The following concentrations of
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CdCl2 were used in this study: 5 nM, 20 nM, 200 nM, and 2
μM. They were selected based on the cadmium levels found
in human serum [13]. In half of the culture dishes, the
cadmium-exposed macrophages were additionally incubated
with COX-2 selective inhibitor, NS-398 (50 μM). After 48 h,
the cells were harvested by scraping and the pellets were ob-
tained by centrifugation (800×g, 10 min). Afterwards, the
cool PBS was added to the pellets and the samples were stored
at −80 °C until the following further analyses: the measure-
ment of protein concentration using Micro BCA Protein As-
say Kit (Thermo Scientific, Rockford, USA). The remaining
supernatants were placed in new tubes and stored at −80 °C
until further analyses, that is the extraction and measurement
of PGE2 and TXB2 by ELISA method.
Cyclooxygenase-1 and Cyclooxygenase-2 Gene Expression
Analysis by qRT-PCR
The quantitative analysis of the expression of Ptgs1 and Ptgs2
genes was performed in a two-step reverse transcription PCR.
Total RNA was extracted from cells using RNAqueous Mini
Kit (Life Technologies, USA). The quantity and quality of iso-
lated RNA were determined using the Nanodrop ND-1000
spectrophotometer (NanoDrop Technologies, USA). cDNA
was prepared from 400 ng of total cellular RNA in 20 μl of
reaction volume, using High capacity cDNA Reverse Tran-
scription Kit (Life Technologies, USA) with random primers,
according to manufacturer’s instructions. Quantitative real-time
PCRwas performed in 7500 Fast Real-Time PCR System (Ap-
plied Biosystems, USA), using pre-validated Taqman Gene
Expression Assays (Applied Biosystems, USA) and a FAM-
labeled probe for analyzed genes and a VIC-labeled probe for
endogenous control gene: GAPDH, TaqMan GE Master Mix
(Life Technologies, USA) and 1.5 μl of cDNA for each reac-
tion mix of 15 μl. Every sample was analyzed simultaneously
in two technical replicates; the mean CT values were used for
further investigation. The relative quantification method was
applied in calculations, using 7500 Fast Real-Time PCR Sys-
tem Software (Applied Biosystems, USA). The thresholds were
set manually to compare data between runs andCT values were
extracted. All CT values were normalized to the mean for en-
dogenous controls (GAPDH) for each sample. Analysis of the-
se relative changes in gene expression between samples was
performed using the 2−ΔΔCT method.
The Measurements of Cyclooxygenase-1
and Cyclooxygenase-2 Expression by Western Blotting
Scraping of cells was followed by lysis using lysing buffer
(protease inhibitor, ethylenediaminetetraacetic acid 5 mM;
Sigma Aldrich, Poland) and cell lysates were collected in
−80 °C. Separation of equal amounts of protein (20 μg) was
performed in 10 % sodium dodecylsulfate (SDS)/
polyacrylamide gel electrophoresis followed by transfer to a
nitrocellulose membrane (Thermo Scientific, Pierce Biotech-
nology, USA) at 157 mA for 1.5 h at room temperature. After
blocking the membrane with 5 % (COX-1) or 3 % (COX-2)
non-fat milk in Tris-buffered saline (Sigma Aldrich, Poland)
containing 0.1 % Tween 20 (Sigma Aldrich, Poland) for 1 h at
room temperature, it was incubated with primary antibodies
direct against COX-1 and COX-2 (1:200; Santa Cruz Biotech-
nology, USA) or with a monoclonal anti-β-actin (1:200; clone
AC-74, Sigma Aldrich, Poland) and next with secondary an-
tibodies (goat anti-mouse IgG HRP, 1:2,000; Santa Cruz Bio-
technology, USA). Signals were visualized by chemilumines-
cence (Thermo Scientific, Pierce Biotechnology, USA).
The Measurements of Prostaglandin E2 and Thromboxane B2
Concentrations
PGE2 and TXB2 were extracted from culture supernatants
using Bakerbond columns (Witko Group, Poland). The mea-
surements of PGE2 and TXB2 levels were conducted using
appropriate immunoenzymatic sets (Prostaglandin E2 EIA
Kit, Cayman, USA; Thromboxane B2 EIA Kit, Cayman,
USA) according to manufacturers’ instruction.
Imaging of Cyclooxygenase-1 and Cyclooxygenase-2
Expression
Expression of COX-1 and COX-2 proteins was examined
with confocal microscopy. THP-1 macrophages were grown
on cover glasses in standard in vitro culture conditions. Fur-
ther, cells were washed with PBS and fixed with 4 % buffered
formalin for 15 min in room temperature. After the fixation
and washing with PBS, cells were permeabilized with 0.5 %
solution of Triton X-100 in PBS. After washing with fresh
portion of PBS, cells were incubated with primary antibodies:
mouse anti-COX-1 and mouse anti-COX-2 (Santa Cruz Bio-
technology) in 1:50 dilution, in 4 °C, overnight and then
washed and incubated with secondary antibody: anti-mouse
IgG FITC conjugated, dilution 1:60 (Sigma-Aldrich) in anti-
body diluent (Dako), 30 min in room temperature and after
washing with PBS further with Hoechst 33258, 30 min, room
temperature. The cells were examined under a confocal mi-
croscope (FV1000 confocal with IX81 inverted microscope,
Olympus, Germany); three channel acquisition and sequential
scanning were used for best resolution of signal from Hoechst
33258 and FITC fluorescence. Additionally, fluorescent im-
ages were merged with transition light images.
Statistical Analysis
The statistical analysis of obtained results was conducted
using Statistica 10 software (Statsoft, Poland). The results
were expressed as arithmetical mean±standard deviation
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(SD). The distribution of variables was evaluated using
Shapiro-Wilk W test. The nonparametric tests were used for
further analyses because distribution in most cases deviated
from normal distribution. The results were subjected to
Wilcoxon matched-pair test. The level of significance was
set at p<0.05.
Results
Cadmium at Highest Tested Concentrations Increases
Cyclooxygenase-1 mRNA Expression, While at Low Tested
Concentrations Decreases Protein Expression in THP-1
Macrophages
In macrophages cultured with CdCl2, the mRNA expression
of COX-1 significantly increased (35 %) (p=0.043) for 2 μM
cadmium solution (p=0.043) (Fig. 1). Addition of NS-398
(COX-2 selective inhibitor) to cultures caused significant
upregulation of COX-1 mRNA for 20 nM (p=0.043) and
2 μM (p=0.043) cadmium solution (29 and 84 % increase,
respectively).
The estimation of the effects of cadmium on COX-1 pro-
tein expression was performed using Western blot and immu-
nocytochemistry. The results obtained using these two
methods are consistent. COX-1 protein expression decreased
markedly following exposure to 20 nM (p=0.012) and 200
nM (p=0.012) cadmium solution (19.5 and 27 % decrease,
respectively) (Fig. 1b and c). The images taken by fluores-
cence microscopy confirmed the influence of cadmium solu-
tion on the decrease in COX-1 protein expression (Fig. 2).
Cadmium at Highest Tested Concentrations Increases
Cyclooxygenase-2 mRNA Expression, While It Exerts No
Effect on Protein Levels in THP-1 Macrophages
COX-2 mRNA expression increased in a cadmium
concentration-dependent manner, with significant upregula-
tion for 200 nM (p=0.043) and 2 μM (p=0.027) cadmium
Fig. 1 The effect of cadmium on
COX-1 mRNA and protein ex-
pression in macrophages cultured
with various cadmium solutions.
a COX-1 mRNA expression fol-
lowing cadmium exposure with-
out or with addition of COX-2
selective inhibitor, NS-398; b
COX-1 protein expression (den-
sitometric analysis of protein
normalized to β-actin; c repre-
sentative Western blot following
cadmium exposure. Monocytes/
macrophages were cultured with
cadmium solutions for 48 h. After
incubation, cells were harvested
by scraping and mRNAwas
measured by using real-time PCR
method (n=4) and protein ex-
pression by using Western blot-
ting method (n=3). Asterisk, sta-
tistically significant as compared
with 0 nMCd—cells incubated in
RPMI medium with 10 % FBS
and with DMSO addition
(Wilcoxon test). Number sign,
statistically significant as com-
pared with the experiment 0 nM
Cd with NS-398 (Wilcoxon test)
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solution (18.5 and 40 % increase, respectively) (Fig. 3a). Ad-
dition of COX-2 selective inhibitor, NS-398 to cultures did not
modulate significantly COX-2mRNA expression at most cad-
mium concentrations tested; however, the interaction of cad-
mium at very low concentration (5 nM; p=0.046) and NS-398
resulted in significant downregulation of COX-2 mRNA ex-
pression (p=0.046) (22 % decrease).
The estimation of the effects of cadmium on COX-2 pro-
tein expression was performed using Western blot and immu-
nocytochemistry. The results obtained using these two
methods are consistent. Cadmium at all concentrations tested
in this study did not alter significantly COX-2 protein expres-
sion (Fig. 3b and c). The images taken by fluorescence mi-
croscopy confirmed no effect of cadmium solution on COX-2
protein expression (Fig. 4).
Prostaglandin E2 Production Is Unaltered by Cadmium
Treatment in THP-1 Macrophages
Cadmium used in this study did not significantly affect PGE2
concentrations as compared to control (Fig. 5).
However, the treatment of THP-1 macrophages with both
cadmium and NS-398 caused significant dose-dependent in-
crease (262 to 488 %) in PGE2 concentration as compared to
control (p=0.027 for 5 nM; p=0.027 for 20 nM; p=0.043 for
200 nM; and p=0.043 for 2 μM cadmium solutions).
Cadmium at All Tested Concentrations Does Not
Significantly Affect Thromboxane A2 Production in THP-1
Macrophages
Treatment of THP-1 macrophages at 200 and 2,000 nM of
cadmium resulted in insignificant decrease (19 to 41 %) in
TXB2 concentrations as compared to control (Fig. 6). How-
ever, co-incubation of macrophages with cadmium and selec-
tive COX-2 inhibitor, NS-398, resulted in the opposite effect,
that is increase (28 to 153 %) in TXB2 concentration, with the
highest tested cadmium concentration (2 μM Cd) causing
marked increase (153 %) in TXB2 level, as compared to con-
trol (p=0.043). Addition of NS-398 to cadmium treated mac-
rophages’ cultures caused significant increase in TXB2
Fig. 2 Imaging of COX-1 en-
zyme by fluorescence microscopy
in macrophages cultured with
cadmium. Monocytes/
macrophages were cultured with
Cd solutions for 48 h. The im-
munohistochemistry was per-
formed using specific primary
antibody, mouse anti-COX-1 (the
overnight incubation at 4 °C), and
secondary antibodies conjugated
with flouorochrome–anti-mouse
IgG FITC (incubation for 45 min
at room temperature). The nuclei
of cells were DAPI stained. Image
analysis was performed with a
fluorescent microscope using fil-
ters 38 HE GFP for green fluo-
rescence and 49 DAPI for blue
fluorescence
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production for 20 nM (p=0.05), 200 nM (p=0.05), and 2 μM
(p=0.043) cadmium solutions.
Discussion
The current study, to the best of our knowledge, is the first such
study in which the effects of very low and low concentrations of
cadmium (comparable to those occurring in the blood serum of
general population or occupationally exposed workers) on inflam-
matory enzymes such as COX-1 and COX-2 and their products
were analyzed using THP-1 macrophage experimental system.
Cadmium and Cyclooxygenases mRNA Expression
We demonstrated that 48 h treatment of THP-1 macrophages
with 2 μM cadmium significantly increased COX-1 mRNA
expression. Similar results were reported by Miyahara et al.
who showed that cadmium at 1 μM and above significantly
increased the level of COX-1 mRNA in primary mouse oste-
oblastic cells [17]. The opposite results were reported by
Figueiredo-Pereira et al.; the authors demonstrated that
COX-1 gene expression was not upregulated by cadmium
treatment (3–30 μM) in HT4 mouse neuronal cells [16].
The observed increased COX-1mRNA expression due to the
highest tested cadmium concentration may be explained by sev-
eral mechanisms. COX-1 gene regulatory elements include three
SP1 binding sites and AP-1 binding site [7]. Cadmium, in con-
centration range 0.5–20 μM,was found to induce the expression
of c-fos and c-jun genes (genes that constitute AP-1 transcription
factor) in different biological systems [30, 31]. We speculate that
48 h exposure of macrophages to 2 μM Cd might significantly
activate AP-1 transcription factor, which in turn could signifi-
cantly induce COX-1 gene promoter through enhanced binding
AP-1 to DNA, resulting in increased COX-1 mRNA levels.
Another possible mechanism responsible for increased COX-1
mRNA expression due to cadmium may be cadmium effects on
secondary messengers, such as ROS or intracellular Ca2+ [10].
Although cadmium is not a Fenton metal, it causes generation of
Fig. 3 The effect of cadmium on
COX-2 mRNA and protein ex-
pression in macrophages cultured
with various cadmium solutions.
a COX-2 mRNA expression fol-
lowing cadmium exposure with-
out or with addition of COX-2
selective inhibitor, NS-398; b
COX-2 protein expression (den-
sitometric analysis of protein
normalized to β-actin; c repre-
sentative Western blot following
cadmium exposure. Monocytes/
macrophages were cultured with
cadmium solutions for 48 h. After
incubation, cells were harvested
by scraping and mRNAwas
measured by using real-time PCR
method (n=4) and protein ex-
pression by using Western blot-
ting method (n=3). Asterisk, sta-
tistically significant as compared
with 0 nMCd—cells incubated in
RPMI medium with 10 % FBS
and with DMSO addition
(Wilcoxon test). Number sign,
statistically significant as com-
pared with the experiment 0 nM
Cd with NS-398 (Wilcoxon test)
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ROS; elevated levels of ROS might affect the redox-sensitive
transcription factor AP-1, which could bind to appropriate
COX-1 gene promoter regulatory element, and thus stimulate
COX-1 mRNA expression [31]. Moreover, cadmium might
activate protein kinases (such as protein kinase C) through the
increased levels of intracellular Ca2+, resulting in enhanced phos-
phorylation ofAP-1 transcription factor leading to transcriptional
activation of COX-1 gene [10, 32].
Fig. 4 Imaging of COX-2 en-
zyme by fluorescence microscopy
in macrophages cultured with
cadmium. Monocytes/
macrophages were cultured with
Cd solutions for 48 h. The im-
munohistochemistry was per-
formed using specific primary
antibody, mouse anti-COX-2 (the
overnight incubation at 4 °C), and
secondary antibodies conjugated
with flouorochrome–anti-mouse
IgG FITC (incubation for 45 min
at room temperature). The nuclei
of cells were DAPI stained. Image
analysis was performed with a
fluorescent microscope using fil-
ters 38 HE GFP for green fluo-
rescence and 49 DAPI for blue
fluorescence
Fig. 5 The effect of cadmium on quantity of PGE2 in culture
supernatants of macrophages cultured with various cadmium solutions.
Monocytes/macrophages were cultured with cadmium solutions for 48 h.
After incubation, cells were harvested by scraping and PGE2 concentra-
tion was measured by ELISA method (n=6). Number sign, statistically
significant as compared with the experiment 0 nM Cd with NS-398
(Wilcoxon test)
Fig. 6 The effect of cadmium on quantity of TXB2 in culture
supernatants of macrophages cultured with various cadmium solutions.
Monocytes/macrophages were cultured with cadmium solutions for 48 h.
After incubation, cells were harvested by scraping and TXB2 concentra-
tion was measured by ELISA method (n=6). Number sign, statistically
significant as compared with the experiment 0 nM Cd with NS-398
(Wilcoxon test)
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Addition of NS-398 to macrophage cultures treated with
cadmium resulted in significant increase in COX-1 mRNA
expression (for 20 nM and 2 μMCd). Selective COX-2 inhib-
itor NS-398 seems to enhance the stimulatory effect of cad-
mium on COX-1 mRNA levels.
Cadmium at concentrations 200 nM and 2 μM markedly
upregulated COX-2 mRNA expression in THP-1 macrophages
treated for 48 h. These results are in agreement with the results
of the studies of Miyahara et al. [17], Figueiredo-Pereira et al.
[16], Shin et al. [19], Seok et al. [18], and Park et al. [8];
however, it should be stressed that other experimental systems
and usually higher cadmium concentrations were used by those
authors. In contrast, two other studies showed the downregula-
tion of COX-2 mRNA expression by cadmium [14, 15].
With respect to COX-2 gene transcriptional regulation, its
promoter contains many cis-acting regulatory elements, of
them only NF-κB site, CRE, NF-IL6 motifs, and E-box are
known to be involved in the regulation of COX-2 gene ex-
pression [9, 33]. Transcription factors bind to these sites in a
variety of combinations depending on cell type and also which
regulatory pathway is activated [9]. Cadmium was found to
activate NF-κB transcription factor [31]. We speculate that
cadmium in higher tested concentrations (i.e., 200 nM and 2
μM) might cause marked upregulation of NF-κB, enhanced
binding of NF-κB to COX-2 promoter, and COX-2 promoter
activation leading to increased COX-2 mRNA expression.
Similarly to COX-1 gene, also other mechanisms may be re-
sponsible for increased expression of COX-2 gene by cadmi-
um, including effects on secondary messengers (ROS, intra-
cellular Ca2+) and effects on signal transduction cascades in-
volving kinases [10, 31]. For example, cadmium appeared to
activate the following kinases: protein kinase C, mitogen-
activated protein kinase (MAPK) family (ERK, JNK, p38),
stress-activated protein kinase, casein kinase 2, calcium/
calmodulin-dependent kinase II [31].
In our study, incubation ofmacrophages with cadmium and
COX-2 selective inhibitor, NS-398, did not change signifi-
cantly the COX-2 mRNA expression at most Cd concentra-
tions tested; however, the lowest Cd concentration with NS-
398 caused significant downregulation of COX-2 mRNA lev-
el. NS-398 appears to counteract the stimulatory effect of Cd
on COX-2 mRNA levels. Our results seem to be in concert
with the report of Callejas et al., who found that the interaction
of NS-398 and LPS on COX-2 upregulation was not observed
at the mRNA level [34]. In contrast to this, Blais et al. dem-
onstrated that NS-398 enhanced the effects of LPS on tran-
scriptional activation of key inflammatory molecules [35].
Cadmium and Cyclooxygenase-1 and Cyclooxygenase-2
Protein Expression
The expression of COX-1 protein in THP-1 macrophages, as
determined byWestern blotting, decreased significantly following
48 h exposure to 20 and 200 nM Cd. Unfortunately, no studies
have been found in the literature which dealt specifically with the
effects of cadmium on COX-1 at protein level. Barrios-Rodiles
et al. demonstrated that the level of COX-1 remained unaltered in
PMA-differentiated THP-1 macrophages stimulated by other in-
flammatory stimulant which is LPS itself and pretreated with NS-
398 [36]. Maybe the reason for the scarce of reports was the
former opinion that COX-1 is a constitutive enzyme and does
not change during inflammation [4]. However, this opinion ap-
peared to be simplistic. Later on, there was suggestion that COX-
1 contributes to inflammatory response [5], so the recent view is
that both COX-1 and COX-2 enzymes show their activities under
both physiological and pathological conditions, such as inflam-
mation [5, 6].
As mentioned previously, cadmium at concentrations 20 and
200 nM exerted inhibitory effect on COX-1 protein level in
THP-1 macrophages despite the absence of alterations in
COX-1 mRNA level. The observed discrepancy between
COX-1 mRNA and protein levels is not unique, since Gry
et al. compared mRNA and protein profiles of 1,066 gene prod-
ucts in 23 human cell lines and found significant correlations
only in one third of examined mRNA species and corresponding
proteins [37]. This rather weak correlation between COX-1
mRNA and protein levels suggests the existence of some non-
specific effect of cadmium resulting in suppression of COX-1
mRNA translation. Probably, the possible mechanisms of COX-
1 protein downregulation by cadmiummight involve the follow-
ing: changes in its mRNA stability [9], enhanced COX-1 degra-
dation [7], interactionwith COX-1mRNAbinding proteins lead-
ing to inhibition of COX-1 protein synthesis [38], effects on
translation factors [39] (for example, CdCl2 caused significant
decrease in protein level of translation initiation factor 4E,
eIF4E). Similar regulatory mechanisms may also be responsible
for the lack of marked alterations in COX-1 protein expression
due at 2 μM cadmium concentration despite significant upregu-
lation of COX-1 mRNA levels [9, 33, 40].
In our study, the expression of COX-2 protein in THP-1
macrophages was not significantly modulated by cadmium at
all tested concentrations. This result is in agreement with the
results obtained by Alvarez et al. who showed that cadmium
(given to rats in concentration of 15 ppm in drinking water for
3 months) did not modify the expression of COX-2 in rat
prostate [20]. Ahn et al. reported even suppression of COX-
2 expression induced by LPS in RAW 264.7 macrophages by
cadmium [14]. However, it is worth mentioning that most of
available reports demonstrated significant increase in COX-2
protein expression due to cadmium exposure [16, 18, 21–25].
The observed absence of alterations in COX-2 protein
levels despite significant upregulation of its mRNA following
48 h exposure to 200 nM and 2 μM Cd remains to be eluci-
dated. However, one must remember that the regulation of
COX-2 gene expression is very complex, and this heavy metal
may modulate many regulatory mechanisms that operate at
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different levels [30, 38]. We may not exclude cadmium-
mediated suppression of COX-2 protein translation, mecha-
nisms of which might be similar to those described by us as
potential modulators of COX-1 protein translation. We spec-
ulate that the possible effects of cadmium on COX-2 protein
levels might involve the following: changes in COX-2 mRNA
stability [33], the effect on RNA-binding proteins [9], the
effect on miRNAs [7, 41], enhanced COX-2 degradation [7,
38], the effect on translation factors [7, 39].
Cadmium and Prostaglandin E2 Synthesis by THP-1
Macrophages
Cadmium at the concentrations 5 nM–2 μM did not signifi-
cantly modify the PGE2 levels in THP-1 macrophages medi-
um following 48 h exposure. This result is in contrast to other
study results which demonstrated stimulatory effect of cadmi-
um (in general in concentrations of 1 μM and above) on PGE2
production by different cells like HT4 mouse neuronal cells
[16], murine cerebrovascular endothelial cells [18], mouse
osteoblasts [17, 26], neonatal mouse calvaria [27], and mouse
peritoneal macrophages from cadmium-exposed mice
(15 ppm Cd through drinking water for 2 months) [24].
In our study, co-incubation of macrophages with cadmium
and selective COX-2 inhibitor NS-398 for 48 h resulted in
significant dose-dependent increase in PGE2 concentration.
This was an unexpected result, since previous reports showed
inhibitory action of NS-398 on cadmium-stimulated PGE2 pro-
duction in other cell lines [17, 27]. Maybe the increase in PGE2
levels following NS-398 treatment in cadmium-exposed mac-
rophages was the consequence of paradoxical effect of NS-398
in our culture system and experimental conditions.
Cadmium and Thromboxane B2 Synthesis by THP-1
Macrophages
Cadmium at concentrations and exposure duration tested in our
study did not significantly modulate TXB2 production by THP-1
macrophages. This result is in concert with report of Eisenmann
and Miller who analyzed the effects of cadmium on human pla-
cental production of TXB2: two 12 h exposures to cadmium (40
and 100 μM) caused no significant effect on TXB2 levels [28].
The treatment of THP-1 macrophages with both 2 μM cad-
mium and NS-398 for 48 h resulted in increase in TXB2 con-
centration as compared with control. This may also be the con-
sequence of paradoxical effect of NS-398 in our culture system.
As was suggested by Ziemann et al., may be the loss of anti-
inflammatory efficacy of COX-2 selective inhibitor NS-398 at
higher doses occurs through paradoxical activation of NF-κB
and subsequent induction of NF-κB-dependent pro-
inflammatory genes [42]. Blais et al. demonstrated that COX-
2 inhibition increases inflammatory response in the brain dur-
ing systemic immune stimuli [35]. Gilroy and colleagues
showed in carrageenan-induced inflammationmodel in rats that
NS-398 significantly exacerbated inflammation at 48 h [43].
The fact that significantly increased COX-1 and COX-2
mRNA expression at 2 μM Cd were not accompanied with
increased protein and enzymatic activity levels remains to be
resolved. Sovago and Varnagy demonstrated that cadmium(II)
ions may form complexes with all natural amino acids and
peptides [44]. Among the most effective metal binding amino
acids are cysteine, methionine, aspartic acid, and histidine
[44]. Twenty-four amino acid residues were found to line cy-
clooxygenase active site with only one difference between
COX-1 and COX-2 [45]. Maybe the lack of alterations in
COX-1 and COX-2 enzymatic activities is associated with
cadmium interaction with some amino acid residues that con-
stitute the active sites of these enzymes, leading to enzyme
conformational changes affecting the catalytic efficiency of
cyclooxygenases through decreased substrate binding.
Conclusion
In conclusion, our study demonstrates that cadmium at the
highest tested concentrations modulates COX-1 and COX-2
only at mRNA level in THP-1 macrophages; however, the
lower tested cadmium concentrations appear to inhibit COX-
1 protein expression. The stimulatory effect of cadmium on
COXs at mRNA level is not reflected at protein and enzymatic
activity levels, suggesting the existence of some posttranscrip-
tional, translational, and posttranslational events that result in
silencing of those genes’ expression.
Despite the minimal effect of cadmium on COXs found in
this study, we may not exclude the possible cumulative effect
of its action in such low concentrations, which will be the
topic of our future research.
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